Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -6 of 6 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Recurrence of Bladder Cancer After Transurethral Resection With Hexvix

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase IV				Treatment				Approved-not yet active				18 and over				Other				GE-196-001 NCT00785694


2.		Hexvix Cystoscopy for Detection of Bladder Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic				Active				18 and over				Other				PC B305/04 NCT00209157


3.		Early Detection of Polyps and Colon Cancer by Fluorescence Imaging - a Dose-Finding Study

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Diagnostic				Active				18 to 85				Pharmaceutical / Industry				PCCO101/05 NCT00285701


4.		A Dose-Finding Study of MAL and HAL Photodynamic Therapy of Cervical Premalignant Lesions.

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Active				18 and over				Pharmaceutical / Industry				PC CE101/06 NCT00369018


5.		Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) of Cervical Intraepithelial Neoplasia (CIN) Grade 2/3

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Approved-not yet active				18 and over				Pharmaceutical / Industry				PC CE201/08 NCT00708942


6.		Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-Invasive Bladder Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Active				18 and over				Other				GEH-HEX-2007-01 NCT00634621

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute